GLP-1s Work Because You Eat Less. That's Also the Risk.
GLP-1 medications work by quieting appetite, and for most patients that is exactly the point. Less hunger, smaller portions, steady weight loss. What gets less attention is what happens when appetite suppression goes far enough that patients simply are not eating enough to meet their nutritional needs, and why that matters more than most people realize.
A recent case review brought this into sharp focus. Researchers identified several patients on semaglutide who developed Wernicke encephalopathy, a serious neurological condition caused by thiamine deficiency. Every case followed the same pattern. Prolonged nausea, vomiting, or appetite loss led to inadequate food intake, and thiamine stores ran out before anyone caught it. Wernicke encephalopathy is rare, but it is also preventable, and prevention comes down to one thing: someone watching for it before symptoms show up.
This is where I get protective of my patients, because this is exactly the gap that shows up when a GLP-1 prescription comes from a website instead of a physician relationship. A subscription service can renew your prescription every month without ever asking how you are eating, whether you are keeping food down, or whether your labs still look normal. Nobody is tracking your nutritional status because nobody set up a system to track it in the first place. That is not a hypothetical risk. It is exactly the setup that led to the Wernicke encephalopathy cases in the case review.
Thiamine deficiency is not the only nutritional risk on these medications, either. Appetite suppression this significant can also quietly erode protein, fiber, iron, and other micronutrient intake, and by the time a patient notices something is wrong, the deficiency has often been building for weeks or months. This is exactly why ongoing lab monitoring matters, not as a formality, but as the actual safety net that catches problems before they become dangerous.
One of the things that makes it hard to pick up these deficiencies is that they develop over different time frames, depending on how your bodies stores these vitamins and minerals. Developing new symptoms as a side effect months after starting a new medication often gets missed. This is why doctors actually make you come back and keep following up, even though "I've been on this medicine forever. Can't you just refill the prescription?"
Thiamine (B1)
Timeframe: Can develop over weeks in the setting of persistent vomiting or very low intake, which is what makes it dangerous, it does not require months of gradual decline like the others
Symptoms: Confusion, unsteady walking, vision changes, in severe cases progressing to Wernicke encephalopathy. Early symptoms are easy to miss since they can look like simple fatigue or a bad week
Protein
Timeframe: Often earliest to show, often within 4 to 8 weeks
Symptoms: Muscle weakness, fatigue, slower recovery from soreness, hair thinning, and noticeable loss of muscle tone even when the number on the scale looks good
Vitamin D
Timeframe: Often already low at baseline in patients starting GLP-1 therapy, worsens over the first 6 to 12 months
Symptoms: Fatigue, bone or joint aches, mood changes, and increased susceptibility to illness
Vitamin B12
Timeframe: Typically 3 to 6 months in, since reduced stomach acid slows the body's ability to release B12 from food
Symptoms: Fatigue, tingling or numbness in hands and feet, brain fog, mood changes, symptoms that overlap heavily with perimenopause and thyroid issues, which is exactly why it needs a lab check rather than a guess
Iron
Timeframe: Develops more gradually, generally over several months of reduced intake
Symptoms: Fatigue, pale skin, shortness of breath with exertion, brittle nails, restless legs
Calcium, magnesium, and potassium
Timeframe: Gradual, over months, tied to overall reduced food volume
Symptoms: Muscle cramps, irregular heartbeat, weakness, and for calcium and magnesium specifically, contributes to the bone and muscle loss risk that comes with rapid weight loss
Fat-soluble vitamins A, E, and K
Timeframe: Slower to develop, tied to reduced dietary fat intake and delayed gastric emptying, usually a longer-term concern past the first several months
Symptoms: Vision changes, skin changes, and in the case of vitamin K, easy bruising or bleeding
Zinc
Timeframe: Gradual, typically several months to a year of reduced intake, worse in patients who already had low baseline levels from obesity itself
Symptoms: Altered or reduced sense of taste, poor wound healing, hair thinning, increased susceptibility to infections, and skin changes around the mouth and extremities in more advanced cases
Selenium
Timeframe: Slow to develop, generally emerging after many months of consistently low intake
Symptoms: Fatigue, muscle pain or weakness, and reduced immune resistance. Thyroid function can also be affected, since selenium plays a role in thyroid hormone metabolism, which matters given how often thyroid issues get discussed alongside weight management
Copper
Timeframe: Genuinely rare on GLP-1s alone. This one is more often triggered by an interaction rather than diet alone, specifically if a patient is also taking zinc supplements without medical guidance, since high-dose zinc competes with copper for absorption
Symptoms: Anemia that does not respond to iron, and progressive neurological symptoms including numbness, gait problems, and unsteady walking. This is the deficiency most likely to be missed since it mimics other neurological conditions and clinicians do not always think to check it
Here is what that monitoring looks like when it is done right. Before starting a GLP-1 medication, I run baseline labs that include a complete metabolic panel to check kidney and liver function, a complete blood count, a lipid panel, and a hemoglobin A1c or fasting glucose to establish a starting point. I also check thyroid function, since thyroid problems can complicate both weight management and how a patient feels on these medications. Depending on your history, I may also check baseline vitamin D, B12, and iron studies, since starting numbers matter for comparison later. These labs can be run at your local Quest laboratory and typical cost under $75 for the whole set, thanks to our special direct pricing.
Once you are on the medication, periodic monitoring continues rather than stopping after that first visit. I recheck metabolic function and relevant labs at intervals based on your dose, your response, and how you are tolerating the medication. If you are reporting persistent nausea, vomiting, or a significant drop in how much you are actually eating, that is a signal to check thiamine and other micronutrient levels directly rather than waiting for a symptom like confusion or vision changes to show up first. Weight and intake get discussed at every visit, not just weighed and moved past. If your food intake has dropped further than expected, that conversation happens before it becomes a deficiency, not after.
None of this is complicated medicine. It is attentive medicine, and attentive medicine requires an actual physician relationship, not a subscription renewal. If persistent vomiting, appetite loss, or a diet that has shrunk to almost nothing is part of your experience on a GLP-1 medication, that is not something to push through quietly. Reach out. That is exactly the kind of change that should trigger a lab check and a real conversation, not just a refill.
TL:DR on the Study Link: https://onlinelibrary.wiley.com/doi/10.1002/oby.70256
The basics: Semaglutide has been linked to rare cases of Wernicke encephalopathy, a serious brain condition caused by thiamine deficiency.
Who was in the study: Researchers conducted a systematic review of case reports involving patients on semaglutide who developed Wernicke encephalopathy, published in the journal Obesity.
What they did: They reviewed documented cases to identify a common pattern connecting semaglutide use to thiamine deficiency and neurological symptoms.
The results: Every identified case followed the same sequence, prolonged nausea, vomiting, or appetite loss leading to inadequate food intake, followed by thiamine depletion and neurological symptoms consistent with Wernicke encephalopathy.
Why it matters: This is a rare but serious and preventable complication, and prevention depends entirely on a physician watching for the warning signs of poor intake before symptoms progress.
The catch: The evidence comes from a small number of case reports rather than a large controlled study, so the true incidence is unknown and likely very low, but the pattern is consistent and worth taking seriously.
How it works (probably): GLP-1 medications suppress appetite so effectively that some patients eat far too little for an extended period, and thiamine, a vitamin the body cannot store in large reserves, runs out before anyone notices something is wrong.
Working with a physician who orders the right labs at the start and keeps checking along the way is not extra caution. It is the standard of care. Learn more about physician-managed weight management at www.presencemd.net.
Comments